而大观霉素和林可霉素耐药性较高，其耐药率分别为75.4％和50.8％。
Spectinomycine and Lincomycin are high drug resistance, the resistance rates were 75.4% and 50.8%.
经过240周的治疗后，HBV聚合酶的蓄聚率、病毒的耐药率和临床耐药率分别是29%，20%和11%。
After 240 weeks of therapy, the cumulative rates of HBV polymerase mutations, virologic resistance, and clinical resistance were 29%, 20%, and 11%, respectively.
耐药性最强的是灰黄霉素，耐药率达86.6%，其次为氟康唑、伊曲康唑，耐药率分别是19.2%、10.6%。
The strongest drug resistance was griseofulvin, which reached up to 86.6%, followed by fluconazole (19.2%) and itraconazole (10.6 %).
白色假丝酵母菌对氟康唑、酮康唑和制霉菌素的敏感率分别为95.65%、80.43%和89.13%，少数菌株存在耐药现象。
The susceptibility of Saccharomyces albicans to fluconazole, ketoconazole and nystatin was 95.65%, 80.43%, and 89.13%, and a few isolates were resistent to antifungal agents.
对左旋氧氟沙星和复方新诺明的耐药率最低，分别为26%和31%。
The lower resistance rate were 26% and 31% on levofloxacin and cotrimoxazole.
大肠埃希氏菌对链霉素、氨苄青霉素、氯霉素和羧苄青霉素的耐药率也很高，分别为82.4%，99.4%，95.0%和80.0%。
The resistant rates of bacterium coli to streptomycin, ampicillin, chloromycetin and carbenicillin were 82.4%, 99.4%, 95.0% and 80.0%.
鲍氏不动杆菌和铜绿假单胞菌泛耐药菌株检出率分别为7.8%和13.2%；
The rate of A. baumannii and P. aeruginosa pan-resistant strains were 7.8% and 13.2%;
在红霉素耐药金黄色葡萄球菌和凝固酶阴性葡萄球菌中，克林霉素诱导型耐药的检出率分别达38.5%和25.0%。
The rate of inducible resistance to clindamycin was 38.5% and 25.0% in erythromycin-resistant isolates of S. aureus and coagulase-negative Staphylococcus respectively.
在红霉素耐药金黄色葡萄球菌和凝固酶阴性葡萄球菌中，克林霉素诱导型耐药的检出率分别达38.5%和25.0%。
The rate of inducible resistance to clindamycin was 38.5% and 25.0% in erythromycin-resistant isolates of S. aureus and coagulase-negative Staphylococcus respectively.
应用推荐